CORCEPT THERAPEUTICS INC (CORT:NASDAQ)
$95.36 -1.3 (-1.3449%)
Analysed CORCEPT THERAPEUTICS INC (CORT:NASDAQ) News Sources
3 High-Flying Stocks We Steer Clear Of
30-06-2026
yahoo.com
3 Cash-Heavy Stocks with Questionable Fundamentals
07-07-2026
yahoo.com
Why Crinetics Stock Soared 99% This Week
09-07-2026
247wallst.com
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook
12-07-2026
fool.com
A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound
21-07-2026
fool.com
Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know
21-07-2026
fool.com
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
22-07-2026
yahoo.com
Are Medical Stocks Lagging Corcept Therapeutics (CORT) This Year?
23-07-2026
yahoo.com
Corcept Therapeutics (CORT) Is Up 5.3% After Analysts Lift Full-Year Earnings Outlook Significantly
25-07-2026
yahoo.com
Corcept Therapeutics (CORT) Lifted Earnings Outlook, Is The Stock Now Overvalued?
25-07-2026
yahoo.com
What is the current price of CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The current price of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is $95.36.
CORCEPT THERAPEUTICS INC (CORT:NASDAQ) absolute price change since previous trading day?
The absolute price change of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) since the previous trading day is $-1.3.
CORCEPT THERAPEUTICS INC (CORT:NASDAQ) percentage price change since previous trading day?
The percentage price change of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) since the previous trading day is -1.3449%.
What is the most recent average sentiment score for CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The most recent average sentiment score for CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The most recent sentiment for CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is .
SEC-8K** Filing Available For CORCEPT THERAPEUTICS INC (CORT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.